Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients
Opioid-Sparing Interdisciplinary Interventions Addressing Pain in Head and Neck Cancer Patients
2 other identifiers
interventional
28
1 country
1
Brief Summary
This phase II trial compares different pain management interventions (standard of care \[SOC\], neurofeedback \[NFB\] training, and compassionate high alert team \[CHAT\]) in patients diagnosed with head and neck cancer who are at risk of developing non-medical opioid use (NMOU). The current standard treatment includes regular clinic visits and supportive care and counseling (including topics like patient-doctor communication, cancer care goals, financial issues counseling, and other topics). NFB training is a type of therapy that uses an electroencephalograph (EEG) and a computer software program to measure brain wave activity. The goal of NFB is to help teach patients with pain how to change their own brain waves to lower their feelings of pain and help improve their quality of life. CHAT is a supportive care intervention that includes symptom and pain management, counseling (about pain, symptoms, opioid use and safety, stress, and quality of life), and support for patients and their family members. NFB and CHAT may help to manage pain and lower patient use of opioids.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Oct 2021
Longer than P75 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2021
CompletedStudy Start
First participant enrolled
October 8, 2021
CompletedFirst Posted
Study publicly available on registry
October 13, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 31, 2027
May 4, 2026
April 1, 2026
6.1 years
September 22, 2021
April 28, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Frequency of non-medical opioid use (NMOU) behaviors
Composite NMOU score is calculated by summing the number of times each behavior suggestive of NMOU is recorded.
through study completion, an average of a year.
Study Arms (3)
ARM I (CHAT)
EXPERIMENTALPatients participate in CHAT counseling intervention over 45-60 minutes twice a month for up to 12 weeks.
ARM II (NFB)
EXPERIMENTALPatients undergo NFB intervention over 20-30 minutes twice a week for up to 10 weeks.
ARM III (SOC)
ACTIVE COMPARATORPatients receive 2-3 standard of care sessions per month over 45-60 minutes for up to 12 weeks.
Interventions
Participate in CHAT counseling intervention
Eligibility Criteria
You may qualify if:
- Diagnosis of HNC, with patient scheduled to receive radiation therapy, with or without evidence of active disease
- Willingness to be seen in the outpatient supportive care center (SCC)
- History of use of non-medical opioid use (Screener and Opioid Assessment for Patients with Pain \[SOAPP\] \>= 7+ and/or Cut Down, Annoyed, Guilty, and Eye opener questionnaire \[CAGE\] \>= 2+)
- Physician-estimated prognosis of at least 12 months
- Age 18 or older
- Able to complete study assessments
- Willing to sign written informed consent
- Both human papillomavirus (HPV) and non-HPV patients will be included
- Patients currently receiving opioids for at least 1 week
- Able to read, write and speak English
You may not qualify if:
- Individual with clinically evident impaired cognition by Memorial Delirium Assessment Scale (MDAS) score of \>= 13
- Employees of MD Anderson Cancer Center
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sriram Yennu
M.D. Anderson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 22, 2021
First Posted
October 13, 2021
Study Start
October 8, 2021
Primary Completion (Estimated)
October 31, 2027
Study Completion (Estimated)
October 31, 2027
Last Updated
May 4, 2026
Record last verified: 2026-04